Translocation, Exocytosis & Endocytosis
More Information »Once proteins are translated, they must be directed to the appropriate localization within, or outside of the cell. Protein translocation occurs either during translation or after translation and depends on the N'-terminal signal-recognition particle (SRP) interacting with its receptor.
Translocation, Exocytosis & Endocytosis Products
Product Name / Activity
|Disrupts protein translocation to Golgi|
|Selective and reversible p97 inhibitor|
|Potent inhibitor of ER-associated protein degradation and translocation|
|Inhibits Golgi-ER traffic; blocks exocytosis|
|Arrests secretion of soluble and membrane-associated proteins|
|Inhibits nuclear export of proteins; antitumor|
|Antiepileptic; binds SV2A|
|Antibody recognizing PIKfyve|
Find multiple products by catalog number
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.